BIS vs. ARKG ETF Comparison

Comparison of ProShares UltraShort Nasdaq Biotechnology (BIS) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
BIS

ProShares UltraShort Nasdaq Biotechnology

BIS Description

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times the inverse (-2x) of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. It is non-diversified.

Grade (RS Rating)

Last Trade

$17.59

Average Daily Volume

6,677

Number of Holdings *

75

* may have additional holdings in another (foreign) market
ARKG

ARK Genomic Revolution Multi-Sector ETF

ARKG Description Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.

Grade (RS Rating)

Last Trade

$26.53

Average Daily Volume

2,493,422

Number of Holdings *

37

* may have additional holdings in another (foreign) market
Performance
Period BIS ARKG
30 Days -14.49% 12.61%
60 Days -3.71% -5.99%
90 Days -0.42% -15.59%
12 Months -10.18% -12.99%
10 Overlapping Holdings
Symbol Grade Weight in BIS Weight in ARKG Overlap
ADPT D 0.42% 2.77% 0.42%
AMGN B 8.14% 1.31% 1.31%
CRSP F 0.42% 6.64% 0.42%
GH D 0.96% 0.58% 0.58%
INCY D 2.09% 1.59% 1.59%
IONS F 1.02% 3.66% 1.02%
MRNA B 0.83% 3.31% 0.83%
REGN C 4.13% 1.17% 1.17%
VCYT F 0.18% 3.01% 0.18%
VRTX C 7.21% 2.57% 2.57%
BIS Overweight 65 Positions Relative to ARKG
Symbol Grade Weight
GILD F 7.41%
BIIB C 6.12%
ILMN F 5.67%
BMRN F 1.91%
ALNY D 1.6%
VTRS C 1.35%
SNY B 1.29%
NBIX B 1.16%
SRPT B 1.15%
NVCR D 1.1%
JAZZ D 1.03%
TECH B 1.02%
AMRN F 0.85%
BGNE C 0.83%
ACAD F 0.81%
ASND D 0.77%
EXEL F 0.73%
ARWR F 0.65%
BLUE F 0.65%
BBIO F 0.51%
ALLK D 0.49%
UTHR B 0.49%
NKTR B 0.48%
SAGE F 0.48%
BPMC A 0.48%
FGEN F 0.47%
DCPH A 0.43%
AGIO B 0.43%
RARE F 0.42%
MEDP D 0.4%
PTCT C 0.4%
ARGX C 0.4%
AXSM B 0.38%
ALLO F 0.37%
GRFS D 0.36%
IOVA D 0.36%
ALKS F 0.36%
KOD D 0.35%
HALO C 0.35%
QURE F 0.35%
FOLD F 0.32%
APLS F 0.31%
XNCR B 0.26%
MYGN A 0.26%
DNLI D 0.26%
ZLAB F 0.24%
IRWD F 0.24%
ARVN D 0.24%
INSM D 0.23%
FATE F 0.23%
PCRX D 0.22%
GLPG F 0.22%
ITCI C 0.21%
RGNX F 0.21%
ESPR D 0.19%
EDIT F 0.19%
LGND C 0.19%
INVA B 0.18%
ALEC F 0.18%
TBPH C 0.17%
YMAB C 0.16%
CHRS F 0.16%
HCM B 0.15%
NGM D 0.15%
SUPN D 0.15%
BIS Underweight 27 Positions Relative to ARKG
Symbol Grade Weight
TWST B -8.71%
RXRX F -5.94%
CDNA C -5.93%
NTLA F -4.22%
SDGR F -3.94%
BEAM F -3.48%
EXAS F -3.47%
TXG F -3.43%
ARCT F -3.41%
DNA F -3.13%
ACCD F -2.82%
TDOC F -2.71%
VEEV D -2.57%
NRIX C -2.48%
MASS F -1.79%
PACB F -1.63%
QSI D -1.48%
PRME F -1.32%
VERV F -1.25%
CMPS D -1.18%
ABSI D -1.12%
CERS C -1.11%
PATH D -1.03%
BFLY F -0.73%
PSNL B -0.68%
RPTX F -0.67%
NTRA B -0.58%
Compare ETFs